The improvement of recombinant antibody production in Chinese Hamster Ovary (CHOK1) cells is a crucial aspect of biopharmaceutical development. To maximize production, various methods are employed, including protein engineering of the host cells and optimization of growth conditions. Moreover, utilization of advanced bioreactors can significantly